The clinical efficacy of trivalent oral polio vaccine in The Gambia by season of vaccine administration

Journal of Infectious Diseases

Volumn 175, Issue 2 SUPPL., 1997, Pages

  Deming, M S ^a   Linkins, R W ^b   Jaiteh, K O ^b   Hull, H F ^b  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ENVIRONMENTAL TEMPERATURE; EPIDEMIC; FEMALE; GAMBIA; HUMAN; IMMUNOGENICITY; INFANT; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; POLIOMYELITIS; POLIOMYELITIS VIRUS 1; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEASON; TREATMENT FAILURE; VACCINATION; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

EID: 0031029544     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/175.supplement_1.s254     Document Type: Article

References (5)

1. Otten MW, Deming MS, Jaiteh KO, et al. Epidemic poliomyelitis in The Gambia following the control of poliomyelitis as an endemic disease. I. descriptive findings. Am J Epidemiol 1992;135:381-92.
2. Deming MS, Jaiteh KO, Otten MW, et al. Epidemic poliomyelitis in The Gambia following the control of poliomyelitis as an endemic disease. II. Clinical efficacy of trivalent oral polio vaccine. Am J Epidemiol 1992;135:393-408.
3. World Health Organization Collaborative Study Group on Oral Polio Vaccine. Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and The Gambia. J Infect Dis 1995;171:1097-106.
4. Orenstein WA, Bernier RH, Dondero TJ, et al. Field evaluation of vaccine efficacy. Bull World Health Organ 1985;63:1055-68.
5. Gail MH, Lubin JH, Rubenstein LV. Likelihood calculations for matched case-control studies and survival studies with tied death times. Biometrika 1981;68:703-7.